openPR Logo
Press release

Easiest Way to Automate API Testing Just Got Easier with Newest Version of SoapUI Pro

06-07-2018 10:14 AM CET | IT, New Media & Software

Press release from: SmartBear Software

/ PR Agency: BroadPR
SmartBear Announces SoapUI Pro 2.4 with New Native Jenkins Plugin to Simplify CI/CD Integration and Enhanced API Discovery to Instantly Convert API Traffic to Automated API Tests

SOMERVILLE, Mass. – June 6, 2018 – SmartBear, the leader in software quality tools for teams, released a new update to SoapUI Pro, the leading automated API testing tool. SoapUI Pro 2.4 provides a new native Jenkins plugin for fast and easy integration with the popular CI/CD tool and has enhanced the API Discovery capability to instantly convert API traffic to automated API tests. With SoapUI 2.4, SmartBear continues to provide the most powerful, yet easy-to-use API testing capabilities for QA teams that want to move from manual to automated testing to accelerate their software development initiatives.

As organizations move to shift their testing into earlier development phases and adopt Agile practices that incorporate continuous testing, it's necessary to drastically increase Unit and API testing in the development process to ensure robust test coverage across the application and remove flakiness that often plagues tests at the UI level. Previously, conducting large-scale API testing has been hampered by silos between development and testing teams and the requirement for deep technical skills when working with APIs. The enhanced API Discovery capabilities in SoapUI Pro 2.4 solves this problem by allowing testers of any skill level to create advanced API test cases by instantly converting API traffic into full-blown automated API tests. With the addition of the new native Jenkins plugin, which complements the command-line interface for integrating with other CI infrastructure, like TeamCity or Bamboo, SoapUI Pro 2.4 saves hours of time deploying builds. Teams can now select their SoapUI Pro testing suite as a Jenkins Build Step, reducing time spent copying and running commands in a batch execution file like most API testing tools.

“The new API Discovery capability in SoapUI Pro can help bridge the gap between QA and development teams giving QA team members a fast lane to begin testing their REST and SOAP API calls and introducing quality earlier in the development process,” said Christian Wright, EVP and GM, API Business at SmartBear.

The enhanced API Discovery feature in SoapUI Pro complements its already powerful one-click test creation, which uses out-of-the-box assertions to help testers generate complex functional, load, or security API tests with no coding knowledge required. The API Discovery happens inside an internal browser or across a proxy, listening for API calls that are happening beneath the UI layer and then converting those calls into automated API tests. This method of API test creation helps connect the UI and API layers in the testing phase, allowing for the larger adoption of API test automation across an organization.

This update also adds support for JSON Web Token (JWT), a common open source method for creating access tokens, as well as support for RAML 1.0 for legacy APIs that haven't yet been converted to the OpenAPI Specification.

To learn more about SoapUI Pro 2.4, attend this live webinar on Wednesday, June 13 at 9 a.m. EDT and 2 p.m. EDT: https://smartbear.com/resources/webinars/whats-new-readyapi-2-4/

About SmartBear Software
Supporting more than six million software professionals and over 22,000 companies in 194 countries, SmartBear is the leader in software quality tools for teams. The company’s products help deliver the highest quality and best performing software possible while helping teams ship code at nearly impossible velocities. With products for API testing, UI testing, code review and performance monitoring across mobile, web and desktop applications, SmartBear equips every development, testing and operations team member with the tools to ensure quality at every stage of the software cycle. For more information, visit: http://smartbear.com, or for the SmartBear community, go to: LinkedIn, Twitter or Facebook.

Tracy Wemett
BroadPR for SmartBear
Assembly Row
450 Artisan Way
Somerville, MA 02145
+1-617-868-5031
tracy@broadpr.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Easiest Way to Automate API Testing Just Got Easier with Newest Version of SoapUI Pro here

News-ID: 1073169 • Views: 251

More Releases from SmartBear Software

SmartBear to Offer Unmatched GraphQL Support and Enhanced UX with Release of Rea …
https://smartbear.com/news/news-releases/smartbear-to-offer-unmatched-graphql-support-and-e/ ReadyAPI 3.0 focuses on increased efficiency for software teams tasked with accelerating the testing and delivery of high-quality APIs SOMERVILLE, Mass. – Nov. 12, 2019 – SmartBear, the driver behind the industry’s leading tools for ensuring quality software delivery, has released ReadyAPI 3.0. This latest release addresses the increasing requirement for organizations to consistently deliver high-quality APIs in order to meet accelerated business demands within compressed release cycles.
SmartBear Expands Leadership Team with New CMO, Product and Marketing Executives …
https://smartbear.com/news/news-releases/smartbear-expands-leadership-team-with-new-cmo,-pr/ SmartBear Hires Tech Marketing Veteran Cynthia Gumbert as CMO to Support Expanding Markets and Rapid Growth SOMERVILLE, Mass. — July 10, 2019 — SmartBear, the innovator behind the industry’s highest impact tools to build, test, and monitor great software, has strengthened its leadership team with several new additions, including Cynthia Gumbert as Chief Marketing Officer. Additionally, Emmanuel Paraskakis joins the company as Vice President of Product Management, Courtney Cunnane as
SmartBear Further Strengthens Leadership Position by Bringing New Test Automatio …
https://smartbear.com/news/news-releases/smartbear-further-strengthens-leadership-position/ SmartBear Announces New Product Integrations and Functionality to Streamline Development by Bringing Together the Power of Test Automation and Test Management with Native Jira Experience SOMERVILLE, Mass. — April 10, 2019 — SmartBear, the innovator behind the industry’s highest impact tools to build, test, and monitor great software, announced four new product integrations between its test management solution, Zephyr, and its leading test automation tools, SoapUI Pro, TestComplete, CrossBrowserTesting, and
SmartBear Goes All In at Atlassian Summit 2019 in Las Vegas
https://smartbear.com/news/news-releases/smartbear-goes-all-in-at-atlassian-summit-2019/ SmartBear Goes All In at Atlassian Summit 2019 in Las Vegas SmartBear Experts Hit the Stage, Offer Personalized Demos, and Give out Envy-Inducing Prizes at Atlassian Summit – April 9-11, 2019 – Las Vegas SOMERVILLE, Mass. - April 05, 2019 - SmartBear, the innovator behind the industry’s highest impact tools to build, test, and monitor great software, is going all in at Atlassian Summit 2019, taking place on Tuesday, April

All 5 Releases


More Releases for API

Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles.   Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform.   Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Global Biotech API Market Analysis
RNCOS has recently added a new Market Research Report titled, “Global Biotech API Market Analysis” to its report gallery. Biotech APIs contribute a very low share in the global API market with synthetic API’s accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech API’s are sure to see a highly prospective market in the future. As per our